Resmed RMD Earnings Call Transcripts

NYSE RMD
$234.04 -1.70 (-0.72%)
As of: Nov 10, 2026 · 3:59 PM EST
16 earnings calls on file for Resmed, from Q2 2020 to Q1 2027. Each transcript opens in a new tab.
Latest earnings call

Resmed Q1 2027 Earnings Call

Oct 29, 2026 9,994 words · 43 min read
  • Sallilyn SchwartzChief Investor Relations Officer
  • Michael FarrellChairman and Chief Executive Officer
  • Aaron BloomerChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Resmed Earnings Call Transcripts

Calls16
LatestOct 29, 2026
SinceQ2 2020

Fiscal 2027

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 16 Resmed transcripts Register to get access to Resmed’s earnings call transcripts.